Russia’s Ministry of Health has announced the development of an mRNA-based cancer vaccine, scheduled for free distribution to patients beginning in early 2025. This development emerges amid global efforts to harness mRNA technology for cancer treatment. The Science and Implementation The vaccine employs messenger RNA (mRNA) technology. According to Alexander Ginsburg, Director of the Gamaleya National Research Center, pre-clinical trials demonstrate the vaccine’s ability to suppress tumor growth and prevent metastases. “Now it takes quite long to build [personalized vaccines] because computing of how a vaccine, or customized mRNA, should look like uses matrix methods, in mathematical terms,” Ginsburg explained. … Continue reading Russia to Offer Free mRNA Cancer Vaccine for Patients Starting 2025 Amid Tumor Suppression Breakthroughs